Navigation Links
4th Annual Advancing Global Clinical Trials Conference is Announced
Date:4/16/2013

New York, New York (PRWEB) April 16, 2013

The Conference Forum announced the 4th Annual Global Clinical Trials conference will take place on September 18, 2013 at the Fairmont Copley Plaza in Boston, MA.

Led by industry veteran Dr Christopher Gallen, CEO, of the Korean-based life science company, SK BioPharmaceuticals, the 2013 program places special emphases on how to reduce the complexities of global clinical trials.

Brand new this year is a section on Lessons Learned from Unsuccessful Global Clinical Trials led by Dr. Debra Barker, Chief Scientific Officer, Emerging Markets, Novartis.

"We are really pleased with the outpouring of interest from senior-level executives wanting to be part of the speaking faculty to help the industry with global clinical challenges,” Valerie Bowling, Executive Director of The Conference Forum.

The Global Clinical Trials event received a wonderful response from the industry to be part of the event due to the latest industry developments and advancements as well as the event’s history. The extensive speaking faculty includes Dr. Mitchell Katz, Executive Director, Medical Research Operations, Purdue Pharma; Dr. Marielle Cohard-Radice, Vice President, Clinical Development Operations, Daiichi Sankyo Pharma Development; Jodie Morrison, CEO, Tokai Pharmaceuticals; and Ross Pettit, Vice President, Clinical Operations, AMAG Pharmaceuticals.

Exciting new and hot topics addressed include Re-thinking the Patient Experience; Designing Patient-Centric Protocols to Increase Global Patient Engagement and Reducing Protocol Complexity; and an Update on Risk Based Monitoring.

One of the best-rated and most popular sections of the conference is the regional roundtables, where experts with experience from all over the world (including China, India, Japan, Latin America and the EU) answer one-on-one questions, covering such topics as how to work globally with different regulatory agencies and patient recruitment, enrollment and engagement.

There will be many opportunities for networking, with special breaks, a breakfast and a luncheon. The conference has been described by attendees as having a “congenial and friendly atmosphere with fostered communication between speakers and attendees” as well as being “knowledgeable and interesting, interactive and provocative.”

Full program details are available at http://www.theconferenceforum.org.

Participating Companies

AbbVie, AMAG Pharmaceuticals, Bristol-Myers Squibb, Celgene, Daiichi Sankyo, Endo Pharmaceuticals, EnVivo Pharmaceuticals, Genzyme, JANSSEN Alzheimer Immunotherapy, Merck, The Michael J. Fox Foundation for Parkinson’s Research, Millennium: The Takeda Oncology Company, Novartis, Purdue Pharma, SK Bio-Pharmaceuticals, Target Health, Teva Pharmaceuticals, Tokai Pharmaceuticals, United Therapeutics

About The Conference Forum
The Conference Forum develops specialized public and private events and organizes research groups and advisory boards for professionals in the life science industry. The company currently offers conferences for R&D leaders, clinical development professionals, young and established biotech executives, drug delivery professionals and the investment community. Their mission is to create the best content in an ideal forum for the exchange of ideas among peers and networking for pharmaceutical and biotech professionals.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10619464.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Infinata's BioPharm Insight Global Editor Kim Ha to Moderate Panel at 3rd Annual U.S.-China Conference on Strategies for Mining Profits from Pharma Opportunities in China
2. New Obesity Education Program To Premiere At American College of Physicians (ACP) Annual Meeting
3. 12,000 Candles: Texas Fertility Center 27th Annual Baby Reunion, Celebrates 12,000 Babies Born
4. NW Bio 2012 Annual Report Shows Strong Progress And Enhancement Of Leadership Position
5. DIA 2013 49th Annual Meeting to Address Hot Topics Surrounding Patient Therapies
6. Rosetta Genomics Announces Poster Presentations at AACR Annual Meeting 2013
7. Susan Cain Will Kick Off 2013 ASAE Annual Meeting & Exposition, Dan Heath is Closing General Session Speaker
8. Electronic Headband That Detects and Treats Addictive In-Sleep Behavior to be Demonstrated at Annual Holistic Dental Conference by Holistic Technologies
9. Professional Pricing Society Explores New Role of Pricers as Change Agents and Leaders at 24th Annual Spring Conference
10. Upsher-Smith Presents Favorable Phase I Data For USL261, A Novel Formulation Of Intranasal Midazolam, At 65th Annual Meeting Of The American Academy Of Neurology
11. NW Bio To Review Its Leadership Position In Immune Therapy At The 25th Annual Roth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or ... its major shareholders, Clean Technology Fund I, LP and ... based venture capital funds which together hold ... a fully diluted, as converted basis), that they have ... entire equity holdings in Biorem to TUS Holdings Co. ...
(Date:6/27/2016)... ... 27, 2016 , ... Rolf K. Hoffmann, former senior vice ... University of North Carolina Kenan-Flagler Business School effective June 27. , ... with a focus on the school’s international efforts, leading classes and participating in ...
(Date:6/24/2016)... , ... June 24, 2016 , ... While the majority ... as the Cary 5000 and the 6000i models are higher end machines that use ... height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
Breaking Biology Technology:
(Date:6/22/2016)... American College of Medical Genetics and Genomics was once again ... of the fastest-growing trade shows during the Fastest 50 Awards ... Las Vegas . Winners are ... of the following categories: net square feet of paid exhibit ... 2015 ACMG Annual Meeting was ranked 23 out of 50 ...
(Date:6/16/2016)... The global Biometric ... USD 1.83 billion by 2024, according to a ... proliferation and increasing demand in commercial buildings, consumer ... the market growth.      (Logo: ... of advanced multimodal techniques for biometric authentication and ...
(Date:6/3/2016)... 2016 Das DOTM ... Nepal hat ein 44 Millionen ... Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an ... und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale ... teilgenommen, aber Decatur wurde als konformste und ...
Breaking Biology News(10 mins):